Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MAY 17, 2018 FBO #6019
SOLICITATION NOTICE

66 -- Dynabeads CD3/CD28 CTS 10ml

Notice Date
5/15/2018
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
 
ZIP Code
20892-5480
 
Solicitation Number
18011016
 
Archive Date
5/30/2018
 
Point of Contact
Andre M. Moody, Phone: 3014022677
 
E-Mail Address
moodya@cc.nih.gov
(moodya@cc.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The Government intends to a award a fixed price purchase order to Life Technologies, Grand Island, NY 14072. The Department of Transfusion (DTM) at the National Institutes of Health (NIH) Clinical Center (CC), Bethesda, MD has a requirement to procure the supply listed below. Dynabeads CD3/CD28 CTS 10ml -- Catalog #40203D (10ml). The Cell Processing Section is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Dynabeads CD3/CD28 CTS used in ex-vivo isolation, activation and expansion of T Cells modified with engineered T Cell Receptors or T Cells base on Chimeric Antigen Receptors for the treatment of cancer, autoimmune diseases and/or infectious diseases. There are no other manufacturers that can be used to isolate, activate and expand of the T Cells that meet rigorous cGMP criteria. The CPS laboratory manufactures approximately 300 highly specific and regulated products each year. These products are used to treat NCI Surgery Branch cancer patients being treated with tumor infiltrating lymphocytes (TIL), NHBI hematology branch hematopoietic transplant patients being treated with stem cells that have minimal T cells capable of causing graft versus host disease, NHLBI hematology branch cancer patients treated with natural killer cells, NCI Experimental Transplantation and Immunology Branch hematopoietic transplant patients being treated with Th2 and Th1 cells, and NCI Pediatric Oncology Branch Patients with sarcoma being treated with donor lymphocyte infusions and dendritic cell vaccines.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/18011016/listing.html)
 
Place of Performance
Address: NIH, 6707 Democracy Blvd., Suite 106, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN04923494-W 20180517/180515230913-a6633404d80c22b2974a287e2c97056a (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.